CAROLINE MURPHY: Open Payments
NPI 1356725774 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 38 payments from 6 companies in 2025. Trend: 2023 $1,220 · 2024 $937 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $698 |
| Janssen Pharmaceuticals, Inc | 3 | $87 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, SPRAVATO, INVEGA TRINZA, INVEGA SUSTENNA, COBENFY, UZEDY, ARISTADA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
